Skip to main content
©cassis - stock.adobe.com

Popowicz Lab

Our primary research activity is drug discovery with focus on protein-protein interaction and new targets scouting. Protein-protein interactome offer enormous number of Protein-Protein Interactions (PPI) that can be used as therapeutic targets. The applicability of PPI targeting has been confirmed only recently. However, development of PPI modulators is difficult due to lack of substrates that can be used as a starting point for analog development and usually large interfaces with dispersed binding energies. PPI usually require compounds of unique chemical properties seldom found in contemporary screening libraries. We are using structure-based computational methods to identify PPIs modulators. With a help of fragment-based screening, NMR-based SAR evaluation and X-ray crystallography, we design molecules that can serve as a chemical probe to validate PPI therapeutic proof-of-concept and be optimized into drug candidates.

Further, our research interest includes:

  • Multicomponent ligand chemistry, computational synthesis design
  • Integration of fragment based and multicomponent approach
  • Employing transient, dynamic states of the interface to optimize ligands
  • Novel computational techniques in drug discovery
  • SAR by X-ray and NMR
  • Structural biology of the complexes

Our primary research activity is drug discovery with focus on protein-protein interaction and new targets scouting. Protein-protein interactome offer enormous number of Protein-Protein Interactions (PPI) that can be used as therapeutic targets. The applicability of PPI targeting has been confirmed only recently. However, development of PPI modulators is difficult due to lack of substrates that can be used as a starting point for analog development and usually large interfaces with dispersed binding energies. PPI usually require compounds of unique chemical properties seldom found in contemporary screening libraries. We are using structure-based computational methods to identify PPIs modulators. With a help of fragment-based screening, NMR-based SAR evaluation and X-ray crystallography, we design molecules that can serve as a chemical probe to validate PPI therapeutic proof-of-concept and be optimized into drug candidates.

Group members

Dr. Filipe Menezes

Postdoc

Dr. Valeria Napolitano

Postdoc

Dr. Till Siebenmorgen

Postdoc

Dr. Marijke Jansma

Postdoc

Publications

Read more

Popowicz Lab

Contact

Dr. Grzegorz Popowicz

Research Group Leader

  • Twitter: